Tags

Type your tag names separated by a space and hit enter

Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease.
Expert Opin Pharmacother 2006; 7(4):485-8EO

Authors+Show Affiliations

School of Science, Charles Darwin University, PO Box 41246, Casuarina, NT 0811, Australia. s_doggrell@yahoo.com

Pub Type(s)

Journal Article

Language

eng

PubMed ID

16503820

Citation

Doggrell, Sheila A.. "Phosphodiesterase 4 Inhibition With Roflumilast: a New Approach to Pulmonary Disease." Expert Opinion On Pharmacotherapy, vol. 7, no. 4, 2006, pp. 485-8.
Doggrell SA. Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease. Expert Opin Pharmacother. 2006;7(4):485-8.
Doggrell, S. A. (2006). Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease. Expert Opinion On Pharmacotherapy, 7(4), pp. 485-8.
Doggrell SA. Phosphodiesterase 4 Inhibition With Roflumilast: a New Approach to Pulmonary Disease. Expert Opin Pharmacother. 2006;7(4):485-8. PubMed PMID: 16503820.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease. A1 - Doggrell,Sheila A, PY - 2006/3/1/pubmed PY - 2007/8/8/medline PY - 2006/3/1/entrez SP - 485 EP - 8 JF - Expert opinion on pharmacotherapy JO - Expert Opin Pharmacother VL - 7 IS - 4 SN - 1744-7666 UR - https://www.unboundmedicine.com/medline/citation/16503820/Phosphodiesterase_4_inhibition_with_roflumilast:_a_new_approach_to_pulmonary_disease_ L2 - http://www.tandfonline.com/doi/full/10.1517/14656566.7.4.485 DB - PRIME DP - Unbound Medicine ER -